Overview

Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer

Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy following surgery in treating patients who have urinary tract cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Tulane University Health Sciences Center
Treatments:
Carboplatin
Gemcitabine
Ifosfamide
Paclitaxel